NMD Pharma A/S - Group

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.1% 1.1% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 16.7% 21.0%  
Credit score (0-100)  0 0 0 12 5  
Credit rating  N/A N/A N/A BB B  
Credit limit (kEUR)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kEUR) 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -2,392 -4,662  
EBITDA  0.0 0.0 0.0 -3,431 -6,170  
EBIT  0.0 0.0 0.0 -3,431 -6,170  
Pre-tax profit (PTP)  0.0 0.0 0.0 -3,589.6 -6,279.4  
Net earnings  0.0 0.0 0.0 -2,930.6 -5,542.8  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -3,590 -6,279  

 
See the entire income statement

Balance sheet (kEUR) 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 -1,170 5,747  
Interest-bearing liabilities  0.0 0.0 0.0 3,434 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 2,844 6,742  

Net Debt  0.0 0.0 0.0 1,337 -5,848  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -2,392 -4,662  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -94.9%  
Employees  0 0 0 9 14  
Employee growth %  0.0% 0.0% 0.0% 0.0% 55.6%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 2,844 6,742  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 137.1%  
Added value  0.0 0.0 0.0 -3,431.1 -6,170.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 -2.0  

Profitability 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 143.5% 132.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -85.3% -114.7%  
ROI %  0.0% 0.0% 0.0% -99.7% -134.4%  
ROE %  0.0% 0.0% 0.0% -103.0% -129.0%  

Solidity 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 0.0% -29.1% 85.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -39.0% 94.8%  
Gearing %  0.0% 0.0% 0.0% -293.6% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 9.6% 6.4%  

Liquidity 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 0.0 0.7 6.8  
Current Ratio  0.0 0.0 0.0 0.7 6.8  
Cash and cash equivalent  0.0 0.0 0.0 2,096.4 5,847.9  

Capital use efficiency 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -1,169.6 5,747.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
N/A
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -381 -441  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -381 -441  
EBIT / employee  0 0 0 -381 -441  
Net earnings / employee  0 0 0 -326 -396